PharmaTher Entered into a Development Agreement with CCBIO to Develop and Commercialize Wearable Ketamine Delivery Device
Shots: The collaboration will combine PharmaTher’s ketamine formulation with...
Shots: The collaboration will combine PharmaTher’s ketamine formulation with...
Shots: The (SIRONA 2) trial evaluates Cordella PA pressure sensor system in 70 NYH...
Shots: The company reported the commercial availability of Amplatzer steerable del...
Shots: VantAI to receive an upfront & is eligible to receive additional precli...
Shots: Pylarify is the first and only FDA approved AI platform developed to assist...
Shots: Iktos to receive research funding & is eligible to receive additional f...
Incisive News in 3 Shots.